Search research articles
Contact Us
Filters
Showing results (91-100 of 668) with videos related to
Page
of 67
Sort By:
Medicina Clinica
|
February 28, 2003
[Helicobacter pylori, cyclooxygenase-2 and gastric cancer]
Javier P Gisbert, José María Pajares
Medicina Clinica
|
August 30, 2002
[Prevalence of Helicobacter pylori infection in gastroesophageal reflux disease and Barretts esophagus]
Javier P Gisbert, José María Pajares
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 24, 2019
Reply
Adrian G Mcnicholl, Javier P Gisbert
Helicobacter
|
May 3, 2017
Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies
Javier P Gisbert, Adrian G McNicholl
Frontline Gastroenterology
|
August 26, 2017
Monitoring thiopurine metabolites in inflammatory bowel disease
Yago González-Lama, Javier P Gisbert
Helicobacter
|
September 27, 2005
Helicobacter pylori "rescue" therapy after failure of two eradication treatments
Javier P Gisbert, José María Pajares
Gastroenterologia Y Hepatologia
|
April 30, 2013
[Update on the efficacy of triple therapy for Helicobacter pylori infection and clarithromycin resistance rates in Spain (2007-2012)]
Javier Molina-Infante, Javier P Gisbert
Journal of Crohn'S & Colitis
|
September 22, 2019
The Role of Immunomodulators and Biologics in the Medical Management of Stricturing Crohn's Disease
Iago Rodríguez-Lago, Javier P Gisbert
The American Journal of Gastroenterology
|
December 20, 2017
Corrigendum: Research to the N-Power: The Strengths of Networked Clinical Collaboration in Spain
Adrian G McNicholl, Javier P Gisbert
Gut
|
January 4, 2011
Levofloxacin in first-line eradication regimens for Helicobacter pylori: better test antibiotic susceptibility before treating
Javier Molina-Infante, Javier P Gisbert
Page
of 67
Search research articles
Search
Showing results (91-100 of 668) with videos related to
Sort By:
Page
of 67
Medicina Clinica
|
February 28, 2003
[Helicobacter pylori, cyclooxygenase-2 and gastric cancer]
Javier P Gisbert, José María Pajares
Medicina Clinica
|
August 30, 2002
[Prevalence of Helicobacter pylori infection in gastroesophageal reflux disease and Barretts esophagus]
Javier P Gisbert, José María Pajares
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
November 24, 2019
Reply
Adrian G Mcnicholl, Javier P Gisbert
Helicobacter
|
May 3, 2017
Optimization strategies aimed to increase the efficacy of H. pylori eradication therapies
Javier P Gisbert, Adrian G McNicholl
Frontline Gastroenterology
|
August 26, 2017
Monitoring thiopurine metabolites in inflammatory bowel disease
Yago González-Lama, Javier P Gisbert
Helicobacter
|
September 27, 2005
Helicobacter pylori "rescue" therapy after failure of two eradication treatments
Javier P Gisbert, José María Pajares
Gastroenterologia Y Hepatologia
|
April 30, 2013
[Update on the efficacy of triple therapy for Helicobacter pylori infection and clarithromycin resistance rates in Spain (2007-2012)]
Javier Molina-Infante, Javier P Gisbert
Journal of Crohn'S & Colitis
|
September 22, 2019
The Role of Immunomodulators and Biologics in the Medical Management of Stricturing Crohn's Disease
Iago Rodríguez-Lago, Javier P Gisbert
The American Journal of Gastroenterology
|
December 20, 2017
Corrigendum: Research to the N-Power: The Strengths of Networked Clinical Collaboration in Spain
Adrian G McNicholl, Javier P Gisbert
Gut
|
January 4, 2011
Levofloxacin in first-line eradication regimens for Helicobacter pylori: better test antibiotic susceptibility before treating
Javier Molina-Infante, Javier P Gisbert
Page
of 67